ROCKVILLE, Md., July 5 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. , The Medication Adherence Solution, announced today that it will host a mid-year investor update conference call on Tuesday, July 12, at 10:00 AM ET.
The call will provide investors with a mid-year update of the Company's events on July 12, 2005 at 10:00 AM ET.
Interested parties may participate in the conference call by dialing (877) 270-4109 or (706) 679-0560, 5-10 minutes prior to the initiation of the call. A replay of the conference call will be available through July 19, 2005, by dialing (800) 642-1687 or (706) 645-9291 and entering access code 7479762.
About INFORMEDIX
InforMedix has positioned itself for success in the projected billion dollar ePRO industry thanks to years of significant investment in extensive research. Founded in 1997 as an R&D company, the firm spent its initial years developing technology and prototype product for collecting patient information, improving patient/physician communication, and monitoring disease management. A direct outcome of this early jumpstart is the firm's pioneer patent position in the area of medication compliance monitoring and the correlation of dose-response data and its current portfolio of 29 issued or pending patents.
InforMedix went public in 2003 for the purposes of gaining access to the public financial markets and commercializing its flagship product, the Med- eMonitor System. As the only public firm in the ePRO field, the company offers current and prospective clients the highest degree of disclosure and accountability, as well as the financial stability provided by public markets. Moreover, its Board of Directors and Advisory Board members bring keen insight from many of the world's largest pharmas. The firm has also reaped its share of technical recognition through awards and trials that have been published in peer reviewed medical journals.
Med-eMonitor, Med-Expert, Innovation Vitae.
Be sure to visit INFORMEDIX's Web site for Company product and investor information: http://www.informedix.com
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company filings with the Securities and Exchange Commission.
INFORMEDIX HOLDINGS, INC.
InforMedix Holdings, Inc. Medical Adherance Solution Founded 1997 Contact: Bruce Kehr, Georgetown Office Park Chairman and CEO 5880 Hubbard Drive, Email: Bruce.Kehr@InforMedix.com Rockville, MD 20852 Tel: 301/984/1566 Fax: 301/984/9096 Contact: Kathy Price Tel: 212/983/1702x212 Email: Kathy.Price@annemcbride.com The Anne McBride Company http://www.annemcbride.com
InforMedix Holdings, Inc.CONTACT: Bruce Kehr, Chairman and CEO of InforMedix Holdings, Inc., Tel:+1-301-984-1566, Fax: +1-301-984-9096, Bruce.Kehr@InforMedix.com; or KathyPrice of The Anne McBride Company, Tel: +1-212-983-1702 x212, Email:Kathy.Price@annemcbride.com, for InforMedix Holdings, Inc.
Web site: http://www.informedix.com/
